StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE:AMPE opened at $0.00 on Friday. The firm’s 50 day moving average is $0.01 and its 200 day moving average is $0.36. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $7.47. The stock has a market capitalization of $2,497.00, a PE ratio of 0.00 and a beta of 3.67.
Ampio Pharmaceuticals Company Profile
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- Why is the Ex-Dividend Date Significant to Investors?
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- MarketBeat Week in Review – 9/16 – 9/20
- Stock Splits, Do They Really Impact Investors?
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
